- Home
- HBT vs BVS Comparison
HBT vs BVS Comparison
Compare HBT & BVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HBT
- BVS
- Stock Information
- Founded
- HBT 1920
- BVS 2011
- Country
- HBT United States
- BVS United States
- Employees
- HBT N/A
- BVS N/A
- Industry
- HBT Major Banks
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- HBT Finance
- BVS Health Care
- Exchange
- HBT Nasdaq
- BVS Nasdaq
- Market Cap
- HBT 760.3M
- BVS 656.3M
- IPO Year
- HBT 2019
- BVS 2021
- Fundamental
- Price
- HBT $24.98
- BVS $10.01
- Analyst Decision
- HBT Hold
- BVS Strong Buy
- Analyst Count
- HBT 6
- BVS 3
- Target Price
- HBT $24.17
- BVS $15.00
- AVG Volume (30 Days)
- HBT 43.6K
- BVS 240.9K
- Earning Date
- HBT 01-22-2025
- BVS 03-11-2025
- Dividend Yield
- HBT 3.36%
- BVS N/A
- EPS Growth
- HBT 9.18
- BVS N/A
- EPS
- HBT 2.26
- BVS N/A
- Revenue
- HBT $221,390,000.00
- BVS $555,061,000.00
- Revenue This Year
- HBT N/A
- BVS $11.37
- Revenue Next Year
- HBT $1.92
- BVS N/A
- P/E Ratio
- HBT $11.05
- BVS N/A
- Revenue Growth
- HBT N/A
- BVS 10.40
- 52 Week Low
- HBT $18.00
- BVS $3.90
- 52 Week High
- HBT $26.25
- BVS $14.38
- Technical
- Relative Strength Index (RSI)
- HBT 56.83
- BVS 41.73
- Support Level
- HBT $24.97
- BVS $9.74
- Resistance Level
- HBT $25.56
- BVS $10.61
- Average True Range (ATR)
- HBT 0.79
- BVS 0.36
- MACD
- HBT -0.04
- BVS -0.06
- Stochastic Oscillator
- HBT 56.58
- BVS 19.09
About HBT HBT Financial Inc.
HBT Financial Inc provides a comprehensive suite of business, commercial, wealth management, and retail banking products and services to individuals, businesses, and municipal entities throughout Central and Northeastern Illinois and Eastern Iowa. It operates through one reportable segment: community banking.
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.